0001731122-20-000024.txt : 20200108
0001731122-20-000024.hdr.sgml : 20200108
20200108180029
ACCESSION NUMBER: 0001731122-20-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200106
FILED AS OF DATE: 20200108
DATE AS OF CHANGE: 20200108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boenisch Sandra
CENTRAL INDEX KEY: 0001655366
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37606
FILM NUMBER: 20516647
MAIL ADDRESS:
STREET 1: 51 WEST 52ND STREET, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANAVEX LIFE SCIENCES CORP.
CENTRAL INDEX KEY: 0001314052
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 208365999
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 51 W 52ND STREET,
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019-6163
BUSINESS PHONE: 800-689-3939
MAIL ADDRESS:
STREET 1: 51 W 52ND STREET,
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019-6163
FORMER COMPANY:
FORMER CONFORMED NAME: Thrifty Printing Inc.
DATE OF NAME CHANGE: 20050111
4
1
ownership.xml
X0306
4
2020-01-06
0
0001314052
ANAVEX LIFE SCIENCES CORP.
AVXL
0001655366
Boenisch Sandra
51 W 52ND STREET,
7TH FLOOR
NEW YORK
NY
10019-6163
0
1
0
0
PFO & Treasurer
Stock Option (Right to Buy)
2.96
2020-01-06
4
A
0
70000
0
A
2030-01-06
Common Stock
70000
70000
D
The options shall vest upon the achievement of a certain clinical trial milestone with respect to the Issuer's Phase 2 clinical trial program of Anavex(R)2-73 for the treatment of Rett syndrome.
/s/ Sandra Boenisch
2020-01-08